Keywords: Pacific Resarch Institute, FDA, EMEA, Drug approval

Think tank calls for US FDA to forgo approval of drugs cleared by European regulator

Article | 30 July 2010

A new report from the US free-market think tank Pacific Research Institute argues that American patients would benefit if the Food and Drug Administration did not have a monopoly on regulations.

I Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in